Cargando…

Treatment with TNF‐α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease

INTRODUCTION: Peripheral inhibition of tumor necrosis factor (TNF)‐α, outside of the central nervous system, may result in clinical improvement of Alzheimer's disease (AD) outcomes. TNF‐α inhibitors (TNFIs) are effective treatments for various autoimmune conditions and may be effective for prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kern, David M., Lovestone, Simon, Cepeda, M. Soledad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450793/ https://www.ncbi.nlm.nih.gov/pubmed/34584936 http://dx.doi.org/10.1002/trc2.12163

Ejemplares similares

Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications
por: Kern, David M., et al.
Publicado: (2019)

Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery
por: Cepeda, M. Soledad, et al.
Publicado: (2019)

Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014)

Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients
por: Furiati, Sandro C., et al.
Publicado: (2019)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab
por: Chimenti, Maria Sole, et al.
Publicado: (2013)

Dementia in Down’s syndrome: an MRI comparison with Alzheimer’s disease in the general population
por: Mullins, Diane, et al.
Publicado: (2013)

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
por: Kern, David M., et al.
Publicado: (2020)

TNF-α inhibitors: are they carcinogenic?
por: Raval, Girindra, et al.
Publicado: (2010)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial
por: Jung, Sang Youn, et al.
Publicado: (2021)

Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention
por: Torres-Acosta, Noel, et al.
Publicado: (2020)

Treatment resistant depression in women with peripartum depression
por: Cepeda, M. Soledad, et al.
Publicado: (2019)

Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease
por: Lovestone, Simon
Publicado: (2000)

At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study
por: Cepeda, M. Soledad, et al.
Publicado: (2021)

Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry
por: Manders, Sofie H M, et al.
Publicado: (2015)

Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
por: Witte, Torsten
Publicado: (2015)

The GSK3 hypothesis of Alzheimer's disease
por: Hooper, Claudie, et al.
Publicado: (2008)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
por: Jang, Dan-in, et al.
Publicado: (2021)

Psychedelics as a Treatment for Alzheimer’s Disease Dementia
por: Vann Jones, Simon Andrew, et al.
Publicado: (2020)

Carotenoids as potential inhibitors of TNFα in COVID-19 treatment
por: Taghipour, Farzaneh, et al.
Publicado: (2022)

Alzheimer’s Disease, Diagnosis and the Need for Biomarkers
por: Hooper, Claudie, et al.
Publicado: (2008)

Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis
por: Desilet, Luke W., et al.
Publicado: (2020)

Switching TNFα inhibitors: Patterns and determinants
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Treatment patterns of patients diagnosed with major depressive disorder and suicidal ideation or attempt: a U.S. population-based study utilizing real-world data
por: Kern, David M., et al.
Publicado: (2021)

Proton pump inhibitors and the risk of Alzheimer’s disease and non-Alzheimer’s dementias
por: Torres-Bondia, Francisco, et al.
Publicado: (2020)

Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents
por: Wang, Qiaolei, et al.
Publicado: (2020)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

Corrigendum: Psychedelics as a Treatment for Alzheimer's Disease Dementia
por: Vann Jones, Simon Andrew, et al.
Publicado: (2020)

Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
por: Szeto, Jennifer Y.Y., et al.
Publicado: (2016)

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
por: Baird, Alison L., et al.
Publicado: (2015)

Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012)

The economic burden of TNFα inhibitors and other biologic treatments in Norway
por: Norum, Jan, et al.
Publicado: (2011)

Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome
por: Chen, Jing, et al.
Publicado: (2019)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
por: Said, Cynthia, et al.
Publicado: (2013)

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
por: de Jong, Henriëtte M. Y., et al.
Publicado: (2019)

Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019
por: Kern, David M., et al.
Publicado: (2020)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Action of anti-TNF-α drugs on the progression of Alzheimer's disease: A case report
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2015)

Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study
por: Newby, Danielle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_75h995ar0jn2vvi2el453f0gmm